← Back to patent-cliff list
SHC014748M
Tier C — Watch / tradeSHC014748M
-
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：PI3Kδ
Indications (approved)：Chronic lymphocytic leukaemia, Peripheral T-cell lymphoma, Marginal zone B-cell lymphoma, Follicular lymphoma, Non-Hodgkin lymphoma, Haematological malignancy
Regional status
US
-
EU
-
China
Phase II
2020-05-09
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of SHC014748M?
Approved indications include: Chronic lymphocytic leukaemia, Peripheral T-cell lymphoma, Marginal zone B-cell lymphoma, Follicular lymphoma, Non-Hodgkin lymphoma, Haematological malignancy.
When does the SHC014748M patent expire?
No public expiry year is available for SHC014748M yet; this page updates once verified.
How do I get a quote for SHC014748M intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-07